NAME: Shankarappa LAB NO: 12/DE/22

AGE/SEX: ____Y/M RECEIVED ON: 02/12/2022

REF DR.: Manjunath Goroshi REPORTED ON: 04/12/2022

MICROBIOLOGY
CULTURE AND SENSITIVITY REPORT
SOURCE OF SPECIMEN : URINE
REPORT : Proteus vulgaris grown in culture
REMARKS: 103 cfu/ml of urine.
ANTIBIOTIC SENSITIVITY
ANTIBIOTICS Zone ANTIBIOTICS Zone
CIPROFIOXACIN (5 mcg) R CHLORAMPHENICOL(30mcg) R
OFLOXACIN (5 mcg) R CEFEPIME (30 mcg) R
NORFLOXACIN (10 mcg) R CEFTAZIDIME ( 30 mcg) R
LEVOFLOXACIN (5 mcg) R COLISTIN (30 mcg) R
ERYTHROMYCIN (15 mcg) R DOXYCYCLINE (30 mcg) R
CLINDAMYCIN (2 mcg) R AMOXICILLIN/ CLAVULANICACID (30/10 mcg) R
GENTAMICIN (10 mcg) R TETRACYCLINE (30 mcg) R
AMOXYCILLIN (30 mcg) R NITROFURANTOIN (30 mcg) R
CEFTRIAXONE (30 mcg) R NALIDIXIC ACID (30 mcg) R
CEFTAZIDIME/CLAVULANICICACID(30/10 mcg) R MEROPENEM (10 mcg) R
CEFOTAXIME (30 mcg) R AZITHROMYCIN (15 mcg) R
CEFOPERAZONE (30 mcg) R CEFEPIME/TAZOBACTUM (30/10 mcg) R
CEFEPIME/TAZOBACTAM (75/10 mcg) R CEFTRIAXONE/TAZOBACTAM (30/10 mcg) R
CEFADROXIL (30 mcg) R TICARCILLIN/ CLAVULANICACID (30/10 mcg) R
IMIPENEM (10 mcg) 21mm S LINCOMYCIN (10 mcg) R
LINEZOLID (30 mcg) - NETILMYCIN (30 mcg) R
PIPERACILLIN /TAZOBACTUM (100/10 mcg) R TEICOPLANIN (30 mcg) R
AMIKACIN (30 mcg) R METHICILLIN (30 mcg) -
TIGECYCLINE (15mcg) R VANCOMYCIN (30 mcg) -
CEFOPERAZONE/SULBACTAM (75/30 mcg) R TOBRAMYCIN (30 mcg) R
Note : R- Resistant S- Sensitive I -Intermediate.

**END OF REPORT**

Dr. VINAY. P. S Ph.D.

Consultant Microbiologist